Correlation Between Johnson Johnson and ADMA Biologics

Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and ADMA Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and ADMA Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Johnson Johnson and ADMA Biologics, you can compare the effects of market volatilities on Johnson Johnson and ADMA Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of ADMA Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and ADMA Biologics.

Diversification Opportunities for Johnson Johnson and ADMA Biologics

-0.45

Correlation Coefficient

Johnson Johnson  ADMA Biologics

Very good diversification

The 3 months correlation between Johnson and ADMA is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and ADMA Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADMA Biologics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with ADMA Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADMA Biologics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and ADMA Biologics go up and down completely randomly.

Pair Corralation between Johnson Johnson and ADMA Biologics

Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.43 times more return on investment than ADMA Biologics. However, Johnson Johnson is 2.35 times less risky than ADMA Biologics. It trades about 0.15 of its potential returns per unit of risk. ADMA Biologics is currently generating about -0.12 per unit of risk. If you would invest  15,115  in Johnson Johnson on December 3, 2024 and sell it today you would earn a total of  1,613  from holding Johnson Johnson or generate 10.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Johnson Johnson  vs.  ADMA Biologics

Johnson Johnson

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Johnson Johnson are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, Johnson Johnson may actually be approaching a critical reversion point that can send shares even higher in April 2025.

ADMA Biologics

Risk-Adjusted Performance

Very Weak

Over the last 90 days ADMA Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Johnson Johnson and ADMA Biologics

The main advantage of trading using opposite Johnson Johnson and ADMA Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, ADMA Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will offset losses from the drop in ADMA Biologics' long position.

The idea behind Johnson Johnson and ADMA Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..